Site of Metastasis | OS | PFS | CB | |||
---|---|---|---|---|---|---|
HR (CI) | p-value | HR (CI) | p-value | OR (CI) | p-value | |
No lymph node metastases (n = 32) | 1.42 (0.79–2.54) | 0.244 | 1.16 (0.74–1.83) | 0.524 | 0.73 (0.31–1.76) | 0.486 |
Lymph node metastases (n = 58) | – | – | – | – | – | – |
No bone metastases (n = 66) | 0.61 (0.32–1.17) | 0.135 | 0.80 (0.48–1.32) | 0.376 | 2.00 (0.75–5.31) | 0.164 |
Bone metastases (n = 24) | – | – | – | – | – | – |
No liver metastases (n = 50) | 0.42 (0.23–0.78) | 0.006* | 0.60 (0.39–0.93) | 0.024* | 2.64 (1.11–6.28) | 0.028* |
Liver metastases (n = 40) | – | – | – | – | – | – |
No brain metastases (n = 82) | 0.69 (0.29–1.64) | 0.406 | 0.86 (0.40–1.88) | 0.712 | 1.44 (0.32–6.42) | 0.633 |
Brain metastases | – | – | – | – | – | – |
No lung (n = 53) | 1.02 (0.57–1.82) | 0.944 | 1.20 (0.76–1.87) | 0.433 | 1.17 (0.50–2.73) | 0.713 |
Lung metastases (n = 37) | – | – | – | – | – | – |